Drug levels in HIV treatment during pregnancy
Part of Immune system & allergy, Infections clinical trials.
This study measures how HIV medicines move through your body during pregnancy by collecting blood samples after you take your regular treatment. It may help improve understanding of dosing and drug levels in pregnant people living with HIV.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are pregnant and have confirmed HIV infection (positive antibody test and confirmed by an antigen test).
- You can and are willing to sign consent and understand the study basics.
- You are taking combination HIV treatment that includes a specific study medication, taken for at least 2 weeks before the first blood-sampling day.
- You can follow any eating/food instructions that the study gives you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well HIV treatment (ART) and a hormonal birth control method (DMPA shot or implant) work together, using small blood samples. It may help ensure safer, more effective HIV care and contraception for young women.
This trial is a pregnancy registry that collects information about birth outcomes when certain HIV medicines are taken during pregnancy. It helps detect any major birth defects so future pregnancies can be safer.
This study checks how safe and well two HIV medicines work in children ages 6 to under 12. It also measures drug levels in the body to guide dosing and watch for side effects.
This study tests a long-acting injectable HIV prevention medicine called cabotegravir in newborn babies who were exposed to HIV. The goal is to see if it can help protect them from getting HIV.
This early-stage study tests a new HIV medication (VH4524184) to understand how your body absorbs and processes it. You'll take a single dose of the medication with a small amount of radioactive tracer, which helps researchers track where the drug goes in your body.
This study tests how well two different pill combinations work together to prevent HIV and pregnancy. You'll take daily birth control pills and daily HIV prevention pills, and researchers will check your health regularly for about a year.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.